Siamab Therapeutics’ Antibody Drug Conjugates Show Promising Results in Ovarian Cancer
News
On Sept. 12, at the American Association for Cancer Research (AACR)’s 11th Biennial Ovarian Cancer Research Symposium in Seattle, Siamab Therapeutics declared that its new ST1 antibody drug conjugates (ADCs) have ... Read more